Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: September 6, 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a...
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: april 10, 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. SHOW MORE
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published: September 20, 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Phage Display Libraries for Antibody Therapeutic Discovery and Development. SHOW MORE
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...
UDIBI admin_udibi3, 15 de March de 202215 de March de 2022, Uncategorized, 0 Transferon in 2020 SHOW MORE
+ UDIBI admin_udibi3, 1 de June de 20231 de June de 2023, Uncategorized, 0 Published : March 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio More information